Home › Stocks › KLRA

KLRA — KAILERA THERAPEUTICS INC

Reported value held$2.52B
Funds holding (latest)151
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)106
Institutional value$2.69B · 125.49M sh
New / Add / Cut / Exit105 / 1 / 0 / 0 · Updated 2026-11-14
Top-5 / Top-10 concentration59.1% / 73.8%
Institutional holdings change Accumulating +50.0% (+10.00K sh)
Institutional value change Up +20.0%

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 106 SEC-registered investment managers reported holding KLRA (KAILERA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.69B across 125.49M shares. That is +50.0% by share count (+10.00K shares) versus the previous quarter, while reported value moved +20.0%. Ownership is concentrated: the five largest holders account for 59.1% of reported value and the top ten for 73.8%.

Compared with the prior quarter, 105 opened new positions, 1 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of KAILERA THERAPEUTICS INC (KLRA) include BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, ranked by reported 13F value among the 151 institutional holders on this page.

KLRA is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 80 32.48M $371.48M +7.1%
Q2 2026 106 125.49M $2.69B +50.0%
Q1 2026 1 20.00K $26.00K +0.0%
Q4 2025 1 20.00K $23.20K —
Q4 2023 7 142.02K $44.04M +139.9%
Q3 2023 6 45.60K $7.42M —
Q2 2023 1 130.00K $28.19M +983.3%
Q1 2023 1 12.00K $2.18M +114.3%

Over the 8 quarters shown, institutional share counts increased 270558% in aggregate (Q1 2023 → Q3 2026); the largest single-quarter swing was Q2 2023 (+983.3%).

Top Institutional Holders (Q3 2026) — 25 funds

FundSharesValuePortfolio WeightChange
Atlas Venture Life Science Advisors, LLC history 5.17M $59.06M 9.36% Hold
Fidelity Management & Research (FMR) 4.66M $53.22M 0.00% Add
BlackRock Inc 4.57M $52.22M 0.00% Add
Royalty Pharma Sub-Manager, LLC history 2.46M $28.04M 14.29% Hold
STATE STREET CORP 2.24M $25.60M 0.00% New
Siren, L.L.C. history 2.21M $25.29M 0.60% Hold
VANGUARD CAPITAL MANAGEMENT LLC 1.68M $19.21M 0.00% Reduce
VANGUARD PORTFOLIO MANAGEMENT LLC 1.62M $18.50M 0.00% Reduce
Geode Capital Management 1.21M $13.79M 0.00% Add
Marshall Wace 878.20K $10.03M 0.02% New
UBS Group AG 469.58K $5.36M 0.00% Reduce
Franklin Resources 401.44K $5.14M 0.00% Hold
Aberdeen Group plc 432.66K $4.94M 0.01% Add
Walleye Capital LLC 416.85K $4.76M 0.03% New
FEDERATED HERMES, INC. 403.69K $4.61M 0.01% Reduce
Jump Financial, LLC 381.00K $4.35M 0.04% New
BNP PARIBAS FINANCIAL MARKETS 310.27K $3.54M 0.01% Add
VANGUARD FIDUCIARY TRUST CO 290.14K $3.31M 0.00% Hold
EXCHANGE TRADED CONCEPTS, LLC 260.80K $2.98M 0.01% Add
Renaissance Technologies 198.55K $2.27M 0.00% New
ALPS ADVISORS INC 171.74K $1.96M 0.01% Add
Morgan Stanley 155.40K $1.77M 0.00% Add
HRT FINANCIAL LP 151.00K $1.72M 0.01% New
Nuveen, LLC 147.19K $1.68M 0.00% Add
BNY Mellon 140.93K $1.61M 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 25 funds

FundSharesValuePortfolio WeightChange
BAIN CAPITAL INVESTORS LLC history 26.26M $578.41M 12.01% New
Bain Capital Life Sciences Investors, LLC history 22.58M $497.51M 29.58% New
RTW INVESTMENTS, LP history 10.78M $237.41M 2.03% New
CPP Investments 7.30M $160.92M 0.09% New
Atlas Venture Life Science Advisors, LLC history 5.17M $113.92M 12.93% New
Fidelity Management & Research (FMR) 3.97M $87.48M 0.00% New
BlackRock Inc 3.93M $86.55M 0.00% New
PRICE T ROWE ASSOCIATES INC /MD/ 3.53M $77.86M 0.01% New
Citadel Advisors 3.24M $71.39M 0.09% New
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.21M $70.68M 0.10% New
Wellington Management Group 2.92M $64.31M 0.01% New
WELLINGTON MANAGEMENT GROUP LLP 2.92M $64.31M 0.01% New
Royalty Pharma Sub-Manager, LLC history 2.46M $54.09M 22.36% New
Siren, L.L.C. history 2.21M $48.78M 0.99% New
VANGUARD CAPITAL MANAGEMENT LLC 1.69M $37.32M 0.00% New
VANGUARD PORTFOLIO MANAGEMENT LLC 1.65M $36.40M 0.00% New
GEODE CAPITAL MANAGEMENT, LLC 1.13M $24.97M 0.00% New
Geode Capital Management 1.13M $24.97M 0.00% New
Farallon Capital Management history 1.10M $24.23M 0.11% New
FARALLON CAPITAL MANAGEMENT, L.L.C. history 1.10M $24.23M 0.11% New
Frazier Life Sciences Management, L.P. history 1.10M $24.23M 0.53% New
Trails Edge Capital Partners, LP history 984.79K $21.69M 3.44% New
UBS Group AG 972.68K $21.43M 0.01% New
Jupiter Topco LLC 970.86K $21.34M 0.01% New
AMERIPRISE FINANCIAL INC 821.33K $18.09M 0.00% New

Q1 2026 — 1 funds

FundSharesValuePortfolio WeightChange
Ancora Advisors LLC 20.00K $26.00K 0.00% Hold

Q4 2025 — 1 funds

FundSharesValuePortfolio WeightChange
Ancora Advisors LLC 20.00K $23.20K 0.00% New

Q4 2023 — 7 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 50.10K $15.86M 0.02% Add
JPMorgan Chase & Co 50.00K $15.83M 0.00% New
SIMPLEX TRADING, LLC 24.00K $7.60M 0.03% Add
GROUP ONE TRADING LLC 12.00K $3.80M 0.07% Add
Legato Capital Management LLC 1.12K $353.54K 0.05% Reduce
Maven Securities LTD 1.00K $316.51K 0.03% New
Worth Venture Partners, LLC 3.80K $292.79K 0.20% New

Q3 2023 — 6 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 22.40K $3.79M 0.01% New
Twin Tree Management, LP 7.50K $1.27M 0.01% New
SIMPLEX TRADING, LLC 6.70K $1.13M 0.01% New
GROUP ONE TRADING LLC 4.90K $828.54K 0.02% New
Legato Capital Management LLC 2.35K $397.19K 0.06% New
INVESTOR AB 1.75K $4.21K 0.00% New

View all 151 fund holders →

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Atlas Venture Life Science Advisors, LLC 5.17M 5.17M — — — — — — — —
Fidelity Management & Research (FMR) 4.66M 3.97M — — — — — — — —
BlackRock Inc 4.57M 3.93M — — — — — — — —
Royalty Pharma Sub-Manager, LLC 2.46M 2.46M — — — — — — — —
STATE STREET CORP 2.24M — — — — — — — — —
Siren, L.L.C. 2.21M 2.21M — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 1.68M 1.69M — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 1.62M 1.65M — — — — — — — —
Geode Capital Management 1.21M 1.13M — — — — — — — —
Marshall Wace 878.20K — — — — — — — — —
UBS Group AG 469.58K 972.68K — — — — — — — —
Franklin Resources 401.44K 400.02K — — — — — — — —
Aberdeen Group plc 432.66K 140.00K — — — — — — — —
Walleye Capital LLC 416.85K — — — — — — — — —
FEDERATED HERMES, INC. 403.69K 434.07K — — — — — — — —
Jump Financial, LLC 381.00K — — — — — — — — —
BNP PARIBAS FINANCIAL MARKETS 310.27K 7.00K — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 290.14K 290.13K — — — — — — — —
EXCHANGE TRADED CONCEPTS, LLC 260.80K 152.50K — — — — — — — —
Renaissance Technologies 198.55K — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold KLRA?

As of 2026-Q2, 106 institutional funds reported holding KLRA (KAILERA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.69B.

How many shares of KLRA do institutions own?

13F filers reported 125.49M shares of KLRA, worth $2.69B in aggregate at the end of 2026-Q2.

Is institutional ownership of KLRA rising or falling?

Share counts moved +50.0% versus the prior quarter — accumulation.

Who are the top institutional holders of KLRA?

The largest 13F holders are BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, CPP Investments, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.

Who are the major shareholders of KAILERA THERAPEUTICS INC?

The major shareholders of KAILERA THERAPEUTICS INC (KLRA) by reported 13F value are BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, CPP Investments, PRICE T ROWE ASSOCIATES INC /MD/, among 151 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own KLRA" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/KLRA/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →